Study guide
5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
Combined Medical Services Examination UPSC CMS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Pattern
1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths
2 Chapter 2: General Medicine - Cardiology & Respiratory
2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism
3 Chapter 3: General Medicine - Gastroenterology & Hepatology
3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
4 Chapter 4: General Medicine - Nephrology & Endocrinology
4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction
5 Chapter 5: General Medicine - Neurology, Haematology & Infection
5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
6 Chapter 6: General Medicine - Emergency Medicine & Toxicology
6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology
7 Chapter 7: Paediatrics - Neonatology & Child Growth
7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones
8 Chapter 8: Paediatrics - Child Health & Nutrition
8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning
9 Chapter 9: Surgery - General Surgery, Wounds & Shock
9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery
10 Chapter 10: Surgery - Surgical Specialties I
10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi
11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia
11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease
12 Chapter 12: Obstetrics - Antenatal Care & Complications
12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management
13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH
13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care
14 Chapter 14: Gynaecology & Family Planning
14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods
15 Chapter 15: PSM - Epidemiology & Biostatistics
15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing
16 Chapter 16: PSM - Disease Epidemiology & Programmes
16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling
17 Chapter 17: PSM - Health Planning & Environmental Health
17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education
5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
Key Takeaways Explain This Topic AI
Plasmodium falciparum causes severe malaria via PfEMP-1 cytoadherence and microvascular sequestration; IV Artesunate (2.4 mg/kg) is the first-line drug of choice for severe malaria.
Plasmodium vivax and P. ovale form dormant hypnozoites in the liver; eradication requires a 14-day course of Primaquine (0.25 mg/kg daily) after screening for G6PD deficiency.
Typhoid fever displays a step-ladder fever pattern and relative bradycardia (Faget sign); diagnosis relies on Blood culture in Week 1 and Widal test in Week 2.
Ileal perforation over necrotic Peyer's patches is the most dreaded life-threatening complication of Typhoid fever, typically occurring in the 3rd week of illness.
Dengue critical phase occurs during defervescence (Days 3-7) and is characterized by endothelial plasma leakage, hemoconcentration (≥20% rise in HCT), and fluid resuscitation mandates cautious crystalloid use.
Last updated: July 2026
Tropical & Endemic Infections: Malaria, Typhoid & Dengue
Tropical and endemic infectious diseases constitute a major proportion of general medicine questions in UPSC CMS. Mastery of species-specific parasite life cycles, diagnostic timelines (e.g., blood culture vs Widal timing in typhoid), clinical staging of dengue plasma leakage, and national guidelines (NVBDCP) for antimicrobial therapy is required.
1. Malaria
Malaria is caused by intraerythrocytic protozoa of the genus Plasmodium ( P. falciparum, P. vivax, P. ovale, P. malariae, P. knowlesi ), transmitted by the bite of infected female Anopheles mosquitoes.
Clinical Paroxysms & Species Differentiation
Classic malarial paroxysms consist of a Cold stage (chills, severe rigor, 15-60 min) → Hot stage (high fever >40°C, intense headache, 2-6 hrs) → Sweating stage (profuse diaphoresis, defervescence, 2-4 hrs).
Feature Plasmodium falciparum Plasmodium vivax Plasmodium ovale Plasmodium malariae
Fever Periodicity Irregular / Continuous / 36-48h Benign Tertian (48 hours) Benign Tertian (48 hours) Quartan (72 hours)
Liver Stage No hypnozoites (No relapse) Hypnozoites present (Relapse+) Hypnozoites present (Relapse+) No hypnozoites (Recrudescence+)
RBC Age Preference All RBC ages (High parasitemia) Reticulocytes / Young RBCs Reticulocytes / Young RBCs Old / Mature RBCs
RBC Inclusions Maurer's clefts Schüffner's dots Schüffner's dots / James' dots Ziemann's stippling
Microscopic Smear Headphone ring forms , double chromatin dots, crescent / banana-shaped gametocytes . Large ring forms, enlarged amoeboid trophozoites. Oval RBCs with fimbriated borders. Band form trophozoites, rosette schizonts (8 merozoites).
Pathophysiology of Severe P. falciparum Malaria
P. falciparum erythrocyte membrane protein 1 ( PfEMP-1 ) expressed on infected RBC surfaces binds to endothelial receptors ( CD36, ICAM-1, VCAM-1 ), causing cytoadherence, rosetting, and microvascular sequestration . This blocks microvascular blood flow, causing tissue hypoxia and organ dysfunction:
Cerebral Malaria : Sequestration in cerebral capillaries causing unrousable coma (Glasgow Coma Scale <11), convulsions, and symmetric upper motor neuron signs.
Blackwater Fever : Massive intravascular hemolysis resulting in severe hemoglobinuria (dark brown/black urine), jaundice, and acute tubular necrosis / acute kidney injury.
Metabolic Complications : Severe hypoglycemia (exacerbated by quinine-stimulated insulin secretion) and lactic acidosis.
National NVBDCP Treatment Guidelines
Uncomplicated P. falciparum Malaria :
North-Eastern States : Artemether-Lumefantrine (AL) for 3 days + Single dose Primaquine 0.75 mg/kg on Day 2.
Rest of India : Artesunate + Sulfadoxine-Pyrimethamine (AS+SP) for 3 days + Single dose Primaquine 0.75 mg/kg on Day 2.
Uncomplicated P. vivax Malaria :
Chloroquine : 25 mg/kg total dose over 3 days (10 mg/kg Day 1, 10 mg/kg Day 2, 5 mg/kg Day 3).
Primaquine : 0.25 mg/kg daily for 14 days to eradicate liver hypnozoites and prevent relapse.
MANDATORY PRECAUTION : Screen for G6PD deficiency prior to initiating 14-day Primaquine therapy! If G6PD deficient, give Primaquine 0.75 mg/kg weekly for 8 weeks under close supervision.
Severe / Complicated Malaria (Any Species) :
Drug of Choice : IV Artesunate 2.4 mg/kg at 0 hours, 12 hours, and 24 hours, then once daily for at least 24 hours until oral therapy can be tolerated.
Loading diagram... Timeline of Clinical Features and Diagnostic Modalities for Tropical Infections
2. Typhoid (Enteric) Fever
Typhoid fever is a systemic infection caused by Salmonella enterica serovar Typhi (and Paratyphi A, B, C), transmitted via the fecal-oral route through contaminated food and water.
Clinical Progression by Week
Week 1 : Remittent step-ladder fever pattern (rising each day), severe headache, malaise, abdominal pain, constipation (common in adults). Key sign: Relative Bradycardia (Faget Sign) — heart rate inappropriately low for the level of high fever.
Week 2 : Continuous high fever, Rose spots (faint, salmon-pink, evanescent macules on upper abdomen/chest that blanch on pressure), hepatosplenomegaly, abdominal distension, and "pea-soup" diarrhea .
Week 3 : "Typhoid State" (apathy, delirium, coma vigil). High risk of life-threatening complications due to necrosis of hyperplastic Peyer's patches in the terminal ileum:
Intestinal Hemorrhage (sudden drop in temperature and blood pressure, melena).
Ileal Perforation (sudden severe right lower quadrant pain, guarding, rigidity, and pneumoperitoneum / free gas under diaphragm on erect X-ray abdomen).
Week 4 : Gradual resolution or chronic gallbladder carrier state (defined as excretion of S. typhi in stool/urine for >1 year; associated with gallstones).
Diagnostic Workup & Antimicrobial Management
Remember the BASU mnemonic for optimal culture diagnostic yield:
B lood culture: Positive in Week 1 (85-90% sensitive).
A ntibody / Widal test: Positive in Week 2 onwards (Significant titers: TO > 1:160 indicates active acute infection; TH > 1:200 indicates past infection or vaccination).
S tool culture: Positive in Week 3 .
U rine culture: Positive in Week 4 .
Antimicrobial Protocol
First-line Choice (Empiric / Uncomplicated) : Ceftriaxone 2 g IV once daily for 10-14 days OR Oral Azithromycin 500 mg daily for 7 days (due to widespread Nalidixic Acid Resistant S. typhi / NARST and fluoroquinolone resistance).
Chronic Carrier State : Oral Ciprofloxacin 750 mg twice daily for 4 weeks OR Ampicillin for 6 weeks; Cholecystectomy if gallstones present.
3. Dengue Virus Infection
Dengue is caused by an arbovirus (Flaviviridae family, 4 serotypes: DEN-1, DEN-2, DEN-3, DEN-4) transmitted by the daytime-biting Aedes aegypti mosquito. Primary infection confers lifelong immunity to that specific serotype. Secondary infection with a different serotype leads to Antibody-Dependent Enhancement (ADE) , markedly increasing the risk of severe dengue.
Phases of Dengue & Clinical Case Definitions
Febrile Phase (Days 1 - 3) : Sudden high-grade fever, retro-orbital pain, severe myalgia/arthralgia ( "breakbone fever" ), facial flushing, positive Tourniquet Test (>20 petechiae per square inch following cuff inflation halfway between SBP and DBP for 5 minutes).
Critical Phase (Days 3 - 7, coinciding with Defervescence) :
Characterized by systemic vascular endothelial leakage (plasma leakage).
Warning Signs : Persistent vomiting, severe abdominal pain, mucosal bleeding, lethargy, fluid accumulation (pleural effusion, ascites), hepatomegaly >2 cm.
Laboratory Hallmark : Rapid rise in Hematocrit (HCT) ≥20% above baseline (indicating hemoconcentration) accompanied by rapid drop in platelet count (<100,000/mm³).
Dengue Shock Syndrome (DSS) : Severe plasma leakage leading to circulatory collapse, narrow pulse pressure (≤20 mmHg), cold clammy extremities, and hypotension.
Recovery Phase (Days 7 - 10) : Plasma leakage ceases, fluid is reabsorbed. Classic rash appears: "islands of white in a sea of red" (confluent erythematous petechial rash with spared normal skin pockets), sinus bradycardia.
Diagnostic Tests & Fluid Resuscitation
NS1 Antigen ELISA : Positive during early febrile phase ( Days 1 to 5 ).
Dengue IgM ELISA : Becomes positive from Day 5 onwards (indicates acute/recent infection).
Dengue IgG ELISA : High titers within first 1-2 days indicate secondary dengue infection.
Fluid Management Protocol : Judicious IV crystalloid therapy ( 0.9% Normal Saline or Ringer's Lactate ). In critical phase without shock, start at 5-7 mL/kg/hr, titrating down based on HCT and urine output (>0.5 mL/kg/hr).
Platelet Transfusion Guidelines : Platelet transfusion is NOT routinely recommended based solely on low platelet numbers. Indications for platelet transfusion are strictly limited to:
Presence of significant active systemic bleeding .
Emergency surgical procedures.
Severe thrombocytopenia (<10,000/mm³) with high risk of bleeding.